A new formulation of 0.1% hydrocortisone cream with vasoconstrictor activity and clinical effectiveness

SUMMARY A new formulation of hydrocortisone with vasoconstrictor activity has been shown to be effective clinically and was more effective in a 0.1% concentration than 1.0% Hydrocortisone Cream BPC. Its use should obviate the adverse effects of fluorinated steroids.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of dermatology (1951) 1975-05, Vol.92 (5), p.585-588
Hauptverfasser:	WHITEFIELD, M., McKENZIE, A.W.
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Topical Anti-Inflammatory Agents - pharmacology Anti-Inflammatory Agents - therapeutic use Clinical Trials as Topic Clioquinol - administration & dosage Clioquinol - therapeutic use Drug Combinations Eczema - drug therapy Humans Hydrocortisone Placebos Vasoconstrictor Agents - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	SUMMARY A new formulation of hydrocortisone with vasoconstrictor activity has been shown to be effective clinically and was more effective in a 0.1% concentration than 1.0% Hydrocortisone Cream BPC. Its use should obviate the adverse effects of fluorinated steroids.
ISSN:	0007-0963 1365-2133
DOI:	10.1111/j.1365-2133.1975.tb03129.x